BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 19031056)

  • 41. Prevalence of chronic illness in pregnancy, access to care, and health care costs: implications for interconception care.
    Chatterjee S; Kotelchuck M; Sambamoorthi U
    Womens Health Issues; 2008; 18(6 Suppl):S107-16. PubMed ID: 18952460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rising mental health costs: what are we getting for our money?
    Druss BG
    Health Aff (Millwood); 2006; 25(3):614-22. PubMed ID: 16684724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic impact of injuries according to type of injury.
    Lindqvist K
    Croat Med J; 2002 Aug; 43(4):386-9. PubMed ID: 12187514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain.
    Peña P; Sancho J; Rufo M; Martínez S; Rejas J;
    Epilepsy Res; 2009 Feb; 83(2-3):133-43. PubMed ID: 19095410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional variations and determinants of direct psychiatric costs in Sweden.
    Tiainen A; Edman G; Flyckt L; Tomson G; Rehnberg C
    Scand J Public Health; 2008 Jul; 36(5):483-92. PubMed ID: 18635731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost of disorders of the brain in Denmark.
    Olesen J; Sobscki P; Truelsen T; Sestoft D; Jönsson B
    Nord J Psychiatry; 2008; 62(2):114-20. PubMed ID: 18569774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The economic burden of stroke in Italy. The EcLIPSE Study: Economic Longitudinal Incidence-based Project for Stroke Evaluation.
    Gerzeli S; Tarricone R; Zolo P; Colangelo I; Busca MR; Gandolfo C
    Neurol Sci; 2005 Jun; 26(2):72-80. PubMed ID: 15995823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost of disorders of the brain in Luxembourg.
    Bisdorff A; Sobocki P; Cloos JM; Andrée C; Graziano ME;
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (3):347-58. PubMed ID: 17209294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic burden of knee and hip osteoarthritis in Spain.
    Loza E; Lopez-Gomez JM; Abasolo L; Maese J; Carmona L; Batlle-Gualda E;
    Arthritis Rheum; 2009 Feb; 61(2):158-65. PubMed ID: 19177521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cost of systemic sclerosis.
    Bernatsky S; Hudson M; Panopalis P; Clarke AE; Pope J; Leclercq S; St Pierre Y; Baron M;
    Arthritis Rheum; 2009 Jan; 61(1):119-23. PubMed ID: 19116974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The costs of non-insurance in Maryland.
    Waters H; Steinhardt L; Oliver TR; Burton A; Milner S
    J Health Care Poor Underserved; 2007 Feb; 18(1):139-51. PubMed ID: 17337803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The economic burden of cancer in Korea in 2002.
    Kim SG; Hahm MI; Choi KS; Seung NY; Shin HR; Park EC
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):136-44. PubMed ID: 18302650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost measurement of mental disorders in Germany.
    Grupp H; Köenig HH; Konnopka A
    J Ment Health Policy Econ; 2014 Mar; 17(1):3-8. PubMed ID: 24864116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics.
    Fitzgerald PB; Montgomery W; de Castella AR; Filia KM; Filia SL; Christova L; Jackson D; Kulkarni J
    Aust N Z J Psychiatry; 2007 Oct; 41(10):819-29. PubMed ID: 17828655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Annual productivity costs due to cervical cancer mortality in the United States.
    Insinga RP
    Womens Health Issues; 2006; 16(5):236-42. PubMed ID: 17055376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The economic impact of epilepsy].
    Pato-Pato A; Cimas-Hernando I; Lorenzo-González JR; Vadillo-Olmo FJ
    Rev Neurol; 2004 Sep 1-15; 39(5):450-3. PubMed ID: 15378460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct health care costs of occupational asthma in Spain: an estimation from 2008.
    García Gómez M; Urbanos Garrido R; Castañeda López R; López Menduiña P
    Arch Bronconeumol; 2012 Oct; 48(10):355-61. PubMed ID: 22705259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.